Which COVID booster causes fewer side effects? study investigates
NCT ID NCT07051031
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how adults feel after getting either the Novavax or the mRNA COVID-19 booster vaccine. Researchers will track symptoms like fever, fatigue, and headache for a week after vaccination. The goal is to help people understand which vaccine might cause fewer reactions and which they prefer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oregon Health and Sciences University
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?